COSTA MESA, California – 15 March 2011 – IOP Ophthalmics, the premier developer and distributor of specialty surgical technologies for eye surgery, announced plans for exhibition at the American Society of Cataract and Refractive Surgeons, March 26 through 29.
The meeting will be held at the San Diego Convention Center – in San Diego, California.
IOP will showcase its wide range of ophthalmic surgical devices and biologics – including the Ambio Amniotic Membrane Allografts, Molteno Glaucoma Drainage Devices, Tutoplast Processed Allografts and the keraSys Lamellar Patch Grafts.
IOP will be located at Booth 1239.
About IOP Ophthalmics Founded in 1988, IOP, Inc. develops and commercializes specialized, leading-edge surgical technologies for eye surgery. IOP's purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider. IOP currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for cornea, anterior and oculoplastic surgeries.